Companies: 10,795·Total market cap: $144.5T
HilleVax, Inc.

HilleVax, Inc.

HLVXNASDAQHealthcare
$2.09
$-0.01(-0.48%)
Market Cap$104762381
P/E Ratio
52W High$2.17
52W Low$1.34

HilleVax, Inc. (HLVX) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

hlvx · market cap & enterprise value · FMP · as of Sep 17, 2025

Core market cap & key metrics

As of Sep 17, 2025, HilleVax, Inc. (HLVX) has a market cap — also referred to as its net worth or valuation — of $104,762,381, making it one of the top most valuable companies globally. Market Cap = $2.09 × shares outstanding.

Market Cap (Net Worth)$104,762,381hlvx market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0hlvx highest market cap ever
Stock Price$2.09NASDAQ · Sep 17, 2025
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

HilleVax, Inc. (HLVX) has a market cap — also referred to as its net worth or valuation — of $104,762,381 as of Sep 17, 2025, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

HilleVax, Inc. reached its all-time high market cap of $0 on —. Comparing the HilleVax, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare HilleVax, Inc. net worth vs peers and ask how HilleVax, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

HLVX market cap · 6 questions

HilleVax, Inc.'s net worth — measured as market capitalization — is $104,762,381 as of Sep 17, 2025. It ranks #0 globally. Market Cap = $$2.09 (price) × shares outstanding.

HLVX net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.